- Joined
- Nov 13, 2012
- Messages
- 112
- Reaction score
- 36
I contacted our ARRO representatives asking what was being done and what we (residents) could do to help make a change. I will keep everyone updated on their response.
I contacted our ARRO representatives asking what was being done and what we (residents) could do to help make a change. I will keep everyone updated on their response.
I took away from this:
1. Supply has outpaced demand for at least the past 5 years.
2. Future demand is very uncertain with very significant threats to our field. Demand has been flat over the past 5 hears.
3. Thus, I would propose a moratorium on growth of residency positions for at least the next 5 years to reassess whether demand has begun to grow again. This would avoid the job market disasters as in Canada and in radiology.
4. Given the current likely oversupply based on surveys and increasing number of fellowships, and the ability to improve productivity for mild undersupply, there would be minimal risk in slowing growth at this time. There seems to be no willpower to make that happen.
Just curious as to why so many people didn't qualify for the position? I know there are some candidates who may not be a great fit for a private group, but 150 people... Wow!
One only need to look at how badly freestanding centers have absorbed Medicare cuts vs hospital-based centers over the last several years to see that ASTRO and its PAC are totally out of touch with the freestanding pp communityI definitely do feel a disconnect with residency training and "the real world" when it comes to being more practical. I agree that ASTRO needs to do more to look after private groups and not strictly focus on academics.
One only need to look at how badly freestanding centers have absorbed Medicare cuts vs hospital-based centers over the last several years to see that ASTRO and its PAC are totally out of touch with the freestanding pp community
It probably will be. Astro pushed through changes to imrt next year to bundle in igrt charges and split out prostate and breast into a "simple" code that pays less. They wanted to stick it to freestanding "urorads" centers but there is no reason why Medicare can't expand these changes to hospitals once they take effect in the freestanding centers.Once these hospitals start buying out the smaller groups and start driving down salaries with an expected increase in production. I bet you then, ASTRO will start changing their tune. Hopefully by then, it will not be too late.
As far as I know, the payment differences in the simple/complex IMRT codes only apply in the freestanding setting, just like current IGRT technical billing only occurs in the freestanding setting.My understanding is that these changes are in effect now, not limited to freestanding centers and were an effort by ASTRO to limit insurer denials of breast IMRT and acknowledge that IMRT for other sites is more complex. I don't think that this was an effort to undermine urorads or freestanding centers but rather a means to have some control over inevitable reimbursement cuts. IMRT simulation was also bundled with IMRT planning presumably with the understanding that IMRT will always require simulation - so IMRT planning bundled with simulation and IMRT delivery bundled with IGRT. CMS will want more bundled services and perhaps eventually diagnosis based reimbursement. ASTRO will have to negotiate with these constraints.
I was one of the commenters from the audience at the session, which was excellent. I have interviewed ~150-200 people for my private practice and it is definitely harder for people finishing training. Not only are we training too many people, I think we're training residents the wrong way which only makes it worse.
Radiation oncology programs select people with heavy research backgrounds and among the lowest levels of volunteering except for neurology, neurosurgery and vascular surgery (see NRMP data). When you have 23% of matriculating residents with a PhD and 45% with some advanced degree for a field that only has 25-30% of positions in academics, it's a setup for a mismatch at the end of training.
Residency makes it worse; you're then fed the false sense you have to do research to succeed. More publications, less focus on clinical acumen, communication skills than there should be. Once we choose the remarkably talented pool of people to be trained, it's physician-scientist tracks that are highlighted. Where are the programs aiming to train physician-humanists that excel at patient care?
The goal should be to train people well for successful careers they enjoy. My suggestion: any residency program director should be required to visit at least two community practice settings annually. Department chairs should do it once annually. Get out of the ivory tower. Community-based radiation oncology are 70+% of the jobs that you are trying to prepare trainees to fill.
I was one of the commenters from the audience at the session, which was excellent. I have interviewed ~150-200 people for my private practice and it is definitely harder for people finishing training. Not only are we training too many people, I think we're training residents the wrong way which only makes it worse.
Radiation oncology programs select people with heavy research backgrounds and among the lowest levels of volunteering except for neurology, neurosurgery and vascular surgery (see NRMP data). When you have 23% of matriculating residents with a PhD and 45% with some advanced degree for a field that only has 25-30% of positions in academics, it's a setup for a mismatch at the end of training.
Residency makes it worse; you're then fed the false sense you have to do research to succeed. More publications, less focus on clinical acumen, communication skills than there should be. Once we choose the remarkably talented pool of people to be trained, it's physician-scientist tracks that are highlighted. Where are the programs aiming to train physician-humanists that excel at patient care?
The goal should be to train people well for successful careers they enjoy. My suggestion: any residency program director should be required to visit at least two community practice settings annually. Department chairs should do it once annually. Get out of the ivory tower. Community-based radiation oncology are 70+% of the jobs that you are trying to prepare trainees to fill.
I am very happy to see how much discussion the panel has generated. I have some bias here since I helped to put the panel together and served as the first speaker. There are no easy answers.
It is important to take a step back and view the problem through a neutral, patient-centric lens. An undersupply of radiation oncologists is a genuine concern for society and arguably presents a much more serious problem for patients than an oversupply. Declining salaries, longer partnership tracks and tight metropolitan markets are not, by themselves, reasons to alter our course.
On the flip side, we have to acknowledge that program directors face significant perverse incentives to increase residency spots without regard to societal need. Residency expansion restrained only by whether there are sufficient resources to provide acceptable training, does not serve our needs or those of our patients. And as subatomicdoc rightly points out, it is worthwhile to consider whether our residencies are optimally selecting and training medical students for clinical practice.
We are currently at a crossroads in terms of payment policy for oncology services. The payment disparity between freestanding centers and hospitals is widening substantially, making acquisitions and joint ventures inevitable. In spring 2016 Medicare will roll out the Oncology Care Model, which allows medical oncologists to save money by reducing spending on radiation therapy (among other things). Unless our specialty brings forward some viable alternatives, payers are likely to remain focused on payment models that make it difficult for radiation oncologists to share in the savings associated with a transition to value-based care. In my mind, how our specialty handles these challenges will have a larger impact on the job market than anything discussed in this thread, including residency expansion.
ASTRO has been working hard on this issue, and has done an excellent job putting together some preliminary proposals. However, there is a fine balance between advancing models in which payers will have interest and minimizing the economic risk to providers. Hospitals and freestanding centers undoubtedly have disparate interests, but ALL of our specialty societies (ASCO, ASTRO, RTA, etc) have tread very gingerly with payment reform to avoid short-term economic disruption.
I believe that this conservatism will change, but I expect much of the future payment innovation in radiation oncology to occur outside our specialty societies, at the hospital level. MDACC has been a leader in this regard, and I expect the next 5 years to bring a diverse array of payment pilots from a number of oncology systems, many of which will give radiation oncologists a seat at the table and a chance to share the value that's created. It is important that radiation oncology departments participate in these models and mold them in ways that are best for our specialty and our patients. Participation is especially important for private groups that wish to remain independent, since collaboration with the hospitals (and the downstream contracting) will solidify relationships and discourage proliferation of an employment model. Physician groups that sit on the sidelines while the hospitals they staff figure out how to bear financial risk and prove value run a significant risk of being displaced. If we can protect our revenues through meaningful involvement in payment reform and maintain the independence of private practice, it will go a long way to stabilizing the radiation oncology job market.
I am very happy to see how much discussion the panel has generated. I have some bias here since I helped to put the panel together and served as the first speaker. There are no easy answers.
It is important to take a step back and view the problem through a neutral, patient-centric lens. An undersupply of radiation oncologists is a genuine concern for society and arguably presents a much more serious problem for patients than an oversupply. Declining salaries, longer partnership tracks and tight metropolitan markets are not, by themselves, reasons to alter our course.
On the flip side, we have to acknowledge that program directors face significant perverse incentives to increase residency spots without regard to societal need. Residency expansion restrained only by whether there are sufficient resources to provide acceptable training, does not serve our needs or those of our patients. And as subatomicdoc rightly points out, it is worthwhile to consider whether our residencies are optimally selecting and training medical students for clinical practice.
We are currently at a crossroads in terms of payment policy for oncology services. The payment disparity between freestanding centers and hospitals is widening substantially, making acquisitions and joint ventures inevitable. In spring 2016 Medicare will roll out the Oncology Care Model, which allows medical oncologists to save money by reducing spending on radiation therapy (among other things). Unless our specialty brings forward some viable alternatives, payers are likely to remain focused on payment models that make it difficult for radiation oncologists to share in the savings associated with a transition to value-based care. In my mind, how our specialty handles these challenges will have a larger impact on the job market than anything discussed in this thread, including residency expansion.
ASTRO has been working hard on this issue, and has done an excellent job putting together some preliminary proposals. However, there is a fine balance between advancing models in which payers will have interest and minimizing the economic risk to providers. Hospitals and freestanding centers undoubtedly have disparate interests, but ALL of our specialty societies (ASCO, ASTRO, RTA, etc) have tread very gingerly with payment reform to avoid short-term economic disruption.
I believe that this conservatism will change, but I expect much of the future payment innovation in radiation oncology to occur outside our specialty societies, at the hospital level. MDACC has been a leader in this regard, and I expect the next 5 years to bring a diverse array of payment pilots from a number of oncology systems, many of which will give radiation oncologists a seat at the table and a chance to share the value that's created. It is important that radiation oncology departments participate in these models and mold them in ways that are best for our specialty and our patients. Participation is especially important for private groups that wish to remain independent, since collaboration with the hospitals (and the downstream contracting) will solidify relationships and discourage proliferation of an employment model. Physician groups that sit on the sidelines while the hospitals they staff figure out how to bear financial risk and prove value run a significant risk of being displaced. If we can protect our revenues through meaningful involvement in payment reform and maintain the independence of private practice, it will go a long way to stabilizing the radiation oncology job market.
Could you imagine if I had been honest with people up front about my goals? "I want to be an oncologist because I love patients and want to serve them in underserved communities in the middle of the country." I likely wouldn't have matched, or I would have matched at a "bad" program. Although in hind site, those "bad" programs focused on clinical care and likely would have prepared me quite well for my goals.
Thanks for pointing that out, Sheldor. Becquerel correctly pointed out the problem is more than just the number of residency positions. It's the degree to which we present ourselves as doctors, not technicians. It's time to stop patting ourselves on the back for having such smart people enter the field and start being more patient-centered, both in our training and practice.
We also increasingly have the opportunity to explain our value to patients and the public at large. Whether it's face-to-face or online, patients want to know what to expect with treatment. We let medical oncologists, surgeons and others taint opinions on what we offer. Rather than waiting hat in hand for referrals, we can explain how valuable radiotherapy is for cancer treatment. Did you know in some parts of Spain only one of seven men get surgery, most get radiation? It's because in Spain radiation oncologists see part of their responsibility being communication and outreach.
Maybe if we valued communication more in residency, we could be better advocates for patients, expand our value and influence. We need to be proactive, not reactive. Otherwise it's back to the basement.
Who regulates residency positions in Derm or Plastics?
This seems like the most straightforward solution.
How can radiation oncologists be more involved in overall oncology care, formally? It's interesting to me that in some European countries and China, rad/onc and med/onc are one specialty. Med/onc is only 1 year of training (or less, if you remove hematologic malignancies). Instead of 1 year of research, can radiation oncology programs include some formal med/onc training? I know there are roadblocks to this, but recently an int'l oncologist trained to give both systemic therapy and RT was telling me about the advantages of this for patient care.
Very solid post and mirrors my own experiences interviewing new graduates. Way too much emphasis on candidates with PhDs and research experience, and I don't think those skills translate well to private practice. So much of private practice is about building personal relationships with referring doctors (dinners, drinks, etc.) and getting your patients to like you and speak highly of you to the referring doctors...I just didn't see that in the people I was interviewing. Solid CVs, but my referring docs could care less about that. Granted, you want people who excel academically, but 90% of my practice is bread-and-butter cases (breast, prostate, lung) that don't require a PhD to treat.
The problem as summarized by an above poster is the following: "We let medical oncologists, surgeons and others taint opinions on what we offer".
I don't really know how to to fix this "bottom feeding" problem of the specialty. Medical oncology is thought of as the "real oncologists" and they are almost always consulted before radiation oncology gets a chance to see the patient. Med oncs (or a surgeon) ultimately "taint" the options for the patients or ultimately decide if radiation is necessary, then radiation is consulted at that point. I think the problem begins with medical education. Think back to when you were a medical student how many radiation oncologists lectured you? the answer for me was zero, all oncology lectures were taught by surgeons and medical oncologists. Medical students go on to become physicians without any clue whatsoever about the value the specialty offers and its role in cancer care. The level of ignorance in other specialties, even at the attending level, of what radiation oncologists do and offer for patients is incredibly astounding. I can't tell you how many times as a medical student I listened to an attending surgeon, med onc, dermatologist, or internist tell a patient to avoid radiation because it is "bad", when so many of them have no idea what they are talking about. The field needs to be active and vocal about the value it offers beginning at the medical education level and beyond. Even then we will still find ourselves as "bottom dwellers", but how do we fix that? can we even fix that?
I can honestly say that the vast majority of my classmates do not know what radiation oncologists do, and many of them think that it is an integrated radiology residency.
I have a questions for you and perhaps others in this forum who are in the PP setting. Let's say, as a young resident, I am very disillusioned with the academics world already and find myself strongly leaning PP. How much does research really matter during my time as a resident to land a PP job, and how much does it play in your decision to interview an applicant if all you are seeing is their CV? will you think less of an applicant with less research or will you give them a fair shot and actually meet them? Clearly, based on what you are saying, some of the highly published applicants may not actually have what it takes to be in the PP setting per you, where having a personality actually matters, yet I would think these candidates get lots of interviews based on their pedigree....
Excessive amounts raises a flag for me about how much you're really interested in patient care.
Excluding the occasional super weird people you can filter out in a few miliseconds, have you really found a correlation between quantity of research and poor clinical/people skills?
By no means am I suggesting that people who choose academics aren't committed to patient care. If that's what is coming across, I apologize. My comments do not address academics at all. I am simply giving my opinion on thecarbonionangle's question about how research may be perceived from a private practice perspective. Hopefully that makes sense.
I have a questions for you and perhaps others in this forum who are in the PP setting. Let's say, as a young resident, I am very disillusioned with the academics world already and find myself strongly leaning PP. How much does research really matter during my time as a resident to land a PP job, and how much does it play in your decision to interview an applicant if all you are seeing is their CV? will you think less of an applicant with less research or will you give them a fair shot and actually meet them? Clearly, based on what you are saying, some of the highly published applicants may not actually have what it takes to be in the PP setting per you, where having a personality actually matters, yet I would think these candidates get lots of interviews based on their pedigree....
...good understanding of the business of medicine.
There's a line that separates good from bad pp docs.40 Gy in 30 fractions for a bone met.. I kid I kid!
Contract negotiations, how to interact with referring doctors and hospital administrators, how to be politically correct in tumor boards, significance of in-office ancillary services exception, etc. These are the scenarios I discuss when interviewing someone. That being said, it would behoove you NOT to stress hypofractionation, over-use of IMRT, etc. if you want a private practice gig. Don't even joke about it. Rather, stress the legitimate scenarios where you use IMRT where older docs might not use it (endometrial, anal Ca, etc.) and stress newer, high-reimbursing, legitimate modalities like SBRT. It's all a game. Most PP rad oncs practice legitimate medicine, but it's in your best interest to stress the ways you can add to the revenue of a practice rather than discussing ways you're gonna take money away!!
I didn't mean to imply that you were at all. My apologies to you. I guess I just found the answer a little confusing. Try to do some research but not too much. I've never officially been part of a PP, and certainly have not been on the side of finding people to fill those positions. I just felt strongly, at least from the people that we have trained, some of the best suited for success in the community setting have also had exceptionally strong research profiles during residency.
Are these skills something that can be picked up during residency?
I was one of the commenters from the audience at the session, which was excellent. I have interviewed ~150-200 people for my private practice and it is definitely harder for people finishing training. Not only are we training too many people, I think we're training residents the wrong way which only makes it worse.
Radiation oncology programs select people with heavy research backgrounds and among the lowest levels of volunteering except for neurology, neurosurgery and vascular surgery (see NRMP data). When you have 23% of matriculating residents with a PhD and 45% with some advanced degree for a field that only has 25-30% of positions in academics, it's a setup for a mismatch at the end of training.
Residency makes it worse; you're then fed the false sense you have to do research to succeed. More publications, less focus on clinical acumen, communication skills than there should be. Once we choose the remarkably talented pool of people to be trained, it's physician-scientist tracks that are highlighted. Where are the programs aiming to train physician-humanists that excel at patient care?
The goal should be to train people well for successful careers they enjoy. My suggestion: any residency program director should be required to visit at least two community practice settings annually. Department chairs should do it once annually. Get out of the ivory tower. Community-based radiation oncology are 70+% of the jobs that you are trying to prepare trainees to fill.
It is such a shame. 99% of this "research" is driven not by scientific curiosity or a noble aspiration to "cure cancer", whatever that means, but to pad the CV. Those posters at ASTRO - 99% of them are fantastically ridiculous, and would not be allowed to hang at any self-respecting scientific meeting... But unfortunately, everyone - from med students to the departmental chairs - have been sucked into this delusional chest-thumping race where "simply" being a good clinician (OR researcher!) is not enough, where a graduate's worth is measured by the NUMBER (NOT quality!) of the stuff he published... How many times have you heard "Oh, so and so published 12 papers just during residency!" Is this a hot dog eating competition, where the quantity is all that matters?
How I would love to spend the "research time" being in the clinic OR actually doing lab research (but the latter is out of reach also because those of you who have done bench research know that there is NO way of producing a paper after 6 months in a lab)!
.. with more residents now in faculty positions, program directors and chairs are getting pressured to find "coverage" for the new faculty and thus requesting more residency slots... ?
Yeah, I could see that. Academic hospitals are taking over community satellites like crazy, and need someone to staff them. The old guard faculty isn't going to do it. It falls to the new grad who quickly realizes that they are doing the work of a private practitioner for the pay of a junior academic. Obviously, a bad situation. Need a steady flow of new grads to pump through that ringer.I think you are right on the money here